Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07043153

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Using Combination of Albumin to Globulin Ratio and Prognostic Nutritional Index Model for Predicting Disease Activity in Patients With Systemic Lupus Erythematosus

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAlbumin to globulin ratio and prognostic nutritional index modelMeasurement of albumin to globulin ratio and prognostic nutritional index in participants to assess disease activity in systemic lupus erythematosus patients

Timeline

Start date
2025-08-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2025-06-29
Last updated
2025-06-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07043153. Inclusion in this directory is not an endorsement.

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity (NCT07043153) · Clinical Trials Directory